BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 26409788)

  • 1. Regulatory effects of fibroblast growth factor-8 and tumor necrosis factor-α on osteoblast marker expression induced by bone morphogenetic protein-2.
    Katsuyama T; Otsuka F; Terasaka T; Inagaki K; Takano-Narazaki M; Matsumoto Y; Sada KE; Makino H
    Peptides; 2015 Nov; 73():88-94. PubMed ID: 26409788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
    Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
    J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor activity is involved in the osteoblastic differentiation regulated by bone morphogenetic proteins and tumor necrosis factor-α.
    Takano M; Otsuka F; Matsumoto Y; Inagaki K; Takeda M; Nakamura E; Tsukamoto N; Miyoshi T; Sada KE; Makino H
    Mol Cell Endocrinol; 2012 Jan; 348(1):224-32. PubMed ID: 21888945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor-alpha in C2C12 cells.
    Matsumoto Y; Otsuka F; Takano M; Mukai T; Yamanaka R; Takeda M; Miyoshi T; Inagaki K; Sada KE; Makino H
    Mol Cell Endocrinol; 2010 Aug; 325(1-2):118-27. PubMed ID: 20638987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF-alpha inhibits BMP-induced osteoblast differentiation through activating SAPK/JNK signaling.
    Mukai T; Otsuka F; Otani H; Yamashita M; Takasugi K; Inagaki K; Yamamura M; Makino H
    Biochem Biophys Res Commun; 2007 May; 356(4):1004-10. PubMed ID: 17397798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sprouty2 is involved in the control of osteoblast proliferation and differentiation through the FGF and BMP signaling pathways.
    Taketomi T; Onimura T; Yoshiga D; Muratsu D; Sanui T; Fukuda T; Kusukawa J; Nakamura S
    Cell Biol Int; 2018 Sep; 42(9):1106-1114. PubMed ID: 28921936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine 1-phosphate receptor activation enhances BMP-2-induced osteoblast differentiation.
    Sato C; Iwasaki T; Kitano S; Tsunemi S; Sano H
    Biochem Biophys Res Commun; 2012 Jun; 423(1):200-5. PubMed ID: 22659743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposing TNF-α/IL-1β- and BMP-2-activated MAPK signaling pathways converge on Runx2 to regulate BMP-2-induced osteoblastic differentiation.
    Huang RL; Yuan Y; Tu J; Zou GM; Li Q
    Cell Death Dis; 2014 Apr; 5(4):e1187. PubMed ID: 24743742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetyl-11-Keto-β-Boswellic Acid Promotes Osteoblast Differentiation by Inhibiting Tumor Necrosis Factor-α and Nuclear Factor-κB Activity.
    Bai F; Chen X; Yang H; Xu HG
    J Craniofac Surg; 2018 Oct; 29(7):1996-2002. PubMed ID: 29927820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relaxin augments BMP-2-induced osteoblast differentiation and bone formation.
    Moon JS; Kim SH; Oh SH; Jeong YW; Kang JH; Park JC; Son HJ; Bae S; Park BI; Kim MS; Koh JT; Ko HM
    J Bone Miner Res; 2014 Jul; 29(7):1586-96. PubMed ID: 24643989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NEMO-binding domain peptide promotes osteoblast differentiation impaired by tumor necrosis factor alpha.
    Li W; Yu B; Li M; Sun D; Hu Y; Zhao M; Cui CB; Hou S
    Biochem Biophys Res Commun; 2010 Jan; 391(2):1228-33. PubMed ID: 20006586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone morphogenetic protein receptors and bone morphogenetic protein signaling are controlled by tumor necrosis factor-alpha in human bone cells.
    Singhatanadgit W; Salih V; Olsen I
    Int J Biochem Cell Biol; 2006; 38(10):1794-807. PubMed ID: 16797218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional relationship between fibroblast growth factor-8 and bone morphogenetic proteins in regulating steroidogenesis by rat granulosa cells.
    Miyoshi T; Otsuka F; Yamashita M; Inagaki K; Nakamura E; Tsukamoto N; Takeda M; Suzuki J; Makino H
    Mol Cell Endocrinol; 2010 Aug; 325(1-2):84-92. PubMed ID: 20434519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype.
    Phimphilai M; Zhao Z; Boules H; Roca H; Franceschi RT
    J Bone Miner Res; 2006 Apr; 21(4):637-46. PubMed ID: 16598384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic protein-3b (BMP-3b) inhibits osteoblast differentiation via Smad2/3 pathway by counteracting Smad1/5/8 signaling.
    Matsumoto Y; Otsuka F; Hino J; Miyoshi T; Takano M; Miyazato M; Makino H; Kangawa K
    Mol Cell Endocrinol; 2012 Mar; 350(1):78-86. PubMed ID: 22155034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-kappaB.
    Li Y; Li A; Strait K; Zhang H; Nanes MS; Weitzmann MN
    J Bone Miner Res; 2007 May; 22(5):646-55. PubMed ID: 17266397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic AMP Response Element-binding Protein H (CREBH) Mediates the Inhibitory Actions of Tumor Necrosis Factor α in Osteoblast Differentiation by Stimulating Smad1 Degradation.
    Jang WG; Jeong BC; Kim EJ; Choi H; Oh SH; Kim DK; Koo SH; Choi HS; Koh JT
    J Biol Chem; 2015 May; 290(21):13556-66. PubMed ID: 25873397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells.
    Kuo PL; Hsu YL; Chang CH; Chang JK
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1290-9. PubMed ID: 15956019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
    Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
    Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harmine promotes osteoblast differentiation through bone morphogenetic protein signaling.
    Yonezawa T; Lee JW; Hibino A; Asai M; Hojo H; Cha BY; Teruya T; Nagai K; Chung UI; Yagasaki K; Woo JT
    Biochem Biophys Res Commun; 2011 Jun; 409(2):260-5. PubMed ID: 21570953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.